With an FDA approval in hand, ADC Therapeutics has enlisted its old friend Avid Bioservices to rev up commercial manufacturing for its new drug Zynlonta. ADC tapped Avid, which started handling ...
Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of the art 78,000 square foot facility located in Costa Mesa, ...
Avid, the Burlington, Mass.-based technology provider in the media and entertainment industry, has entered into a definitive agreement to be acquired by an affiliate of STG, a private equity partner ...
Avid Bioservices Inc., a dedicated biologics CDMO, has opened its new Early Phase Center of Excellence, a 78,000 square foot facility located in CA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results